Loading
A phase 3 trial of Leucovorin and Tegafur, gimeracil and oteracil in Colorectal cancer, run by Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, completed.
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery is a phase 3 interventional study registered as NCT00660894 by Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, with 1535 participants recorded, started 2008-04 and reaching its primary completion in 2012-06. Interventions recorded: folinate calcium, tegafur-uracil, tegafur-gimeracil-oteracil potassium. Conditions recorded: Colorectal Cancer.
Linked to the drug Tegafur, gimeracil and oteracil because the registry names it among its interventions and Colorectal cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Tegafur, gimeracil and oteracil (S-1), Colorectal cancer and the tag pipeline.
Shares Leucovorin (folinic acid), Colorectal cancer and the tag pipeline.
Shares Leucovorin (folinic acid), Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/